Skip to main content

Table 1 Prostate cancer research consortium patient cohort characteristics

From: Evaluation of prediction models for the staging of prostate cancer

 

PCRC data

OC

NOC

p

 

(n = 603)

(n = 427)

(n = 176)

 

Age (y)

    

Mean (Median)

61.1 (62)

60.7 (61)

62.2 (63)

0.01

Range

42-74

42-74

42-74

 

Family history (%)

    

PCa history

151 (25.0)

107 (25.1)

46 (28.9)

0.70

Ca history

121 (20.1)

85 (19.9)

26 (16.4)

 

No history

331 (54.9)

235 (55.0)

87 (54.7)

 

Clinical stage, DRE (%)

    

T1c

267 (44.3)

188 (44.1)

79(44.9)

0.69

T2a

144 (23.9)

99 (23.1)

45 (25.6)

 

Not reported

192(31.8)

140 (32.8)

52 (39.5)

 

PSA (ng/ml)

    

Mean (Median)

7.96 (7.0)

7.6 (6.7)

8.6 (7.5)

0.02

Range

0.7 – 40

0.7 – 40

2.1 – 36

 

Biopsy GS (%)

    

5

96 (17.4)

77 (19.7)

19 (11.8)

P < 0.001

6

205 (37.1)

163 (41.7)

42 (26.1)

 

3 + 4 = 7

153 (27.7)

103 (26.3)

50 (31.1)

 

4 + 3 = 7

46 (8.3)

22 (5.7)

24 (14.9)

 

8

34 (6.2)

18 (4.6)

16 (9.9)

 

9

18 (3.3)

8 (2.0)

10 (6.2)

 

Prostatectomy GS (%)

    

5

59 (9.8)

46 (10.8)

13 (7.4)

P < 0.001

6

151 (25.0)

125 (29.2)

26 (14.8)

 

3 + 4 = 7

237 (39.3)

181 (42.4)

56 (31.8)

 

4 + 3 = 7

90 (14.9)

44 (10.3)

46 (26.1)

 

8

42 (7.0)

20 (4.7)

22 (12.5)

 

9

24 (4.0)

11 (2.6)

13 (7.4)

 

Pathological stage

   

OC

427 (70)

427 (70)

-

ECE

111 (19)

-

111 (63)

SVI

47 (8)

-

47 (27)

LNI

18 (3)

-

18 (10)